微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.86% | 16.27% | -57.44% | 10/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 11.42% | 18.22% | 5.55% | 14/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 10.82% | 3.24% | 38.72% | 15/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 7.8% | 12.39% | 86.6% | 13/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 4.18% | 8.01% | -56.73% | 15/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 9.66% | 14.05% | -7.82% | 24/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 10.48% | 73.8% | 51.01% | 18/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 6.94% | 62.15% | 79.33% | 17/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 3.87% | 63.98% | -54.31% | 22/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 8.47% | -6.1% | 40.46% | 29/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 6.03% | -6.66% | 40.89% | 37/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 4.28% | -10.83% | 81.36% | 32/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.36% | 21.65% | -73.84% | 34/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 9.02% | 18.68% | 39.63% | 28/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 6.46% | -40.35% | 34.58% | 39/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 4.8% | 2.13% | 147.42% | 31/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 1.94% | -39.56% | -74.47% | 42/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 7.6% | -1.17% | -29.82% | 31/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 10.83% | 24.48% | 130.43% | 14/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 4.7% | 64.91% | 46.42% | 25/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 3.21% | -33.26% | -58.26% | 14/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 7.69% | -49.8% | -11.61% | 35/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 8.7% | -38.99% | 205.26% | 25/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 2.85% | -62.1% | -40.75% | 47/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 4.81% | 10.57% | -68.6% | 7/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 15.32% | -6.64% | 7.43% | 12/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 14.26% | -7.82% | 89.63% | 5/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 7.52% | -13.86% | 72.87% | 15/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 4.35% | -2.68% | -73.49% | 9/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 16.41% | -11.39% | 6.08% | 9/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 15.47% | -5.38% | 77.21% | 3/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 8.73% | -6.83% | 95.3% | 9/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 4.47% | -0.45% | -75.86% | 7/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 18.52% | -12.52% | 13.27% | 9/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 16.35% | -6.52% | 74.49% | 5/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 9.37% | -7.68% | 108.69% | 8/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 4.49% | -7.42% | -78.79% | 10/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 21.17% | -6.99% | 21.04% | 9/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 17.49% | -10.72% | 72.32% | 4/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 10.15% | -8.23% | 109.28% | 8/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 4.85% | -9.85% | -78.69% | 7/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |